Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Pilger, E; Juan, H.
Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy
WIEN KLIN WOCHENSCHR. 1983; 95(8): 263-266.
Web of Science PubMed Google Scholar

Leading authors Med Uni Graz: Pilger Ernst
Co-authors Med Uni Graz: Juan Heinz
Altmetrics:
Dimensions Citations:
Plum Analytics:
Abstract:: Prostaglandin E1 was given intraarterially to twenty persons with severe peripheral ischaemia at risk of requiring amputation of a limb for ischaemic ulcers or necrosis. All patients had received conventional therapy without success before PG E1 treatment. An average dose of 6.14 ng/kg/min of PG E1 was given intraarterially for 2 hrs daily over a period of six days. In fifteen cases PG E1 therapy resulted in complete or partial healing of the ulcers and necrotic areas while the patients no longer suffered from pain at rest. No beneficial effects of PG E1 treatment were seen in five patients. In these cases cases multiple arterial occlusions, caused by arteriosclerosis and diabetes mellitus, existed, in more than three levels. Side effects like pain in the infused limb and swelling of the extremity occurred in fourteen patients, but were reversible in each case.
Find related publications in this database (using NLM MeSH Indexing): Alprostadil -; Amputation -; Arteriosclerosis Obliterans - complications; Humans - complications; Injections, Intra-Arterial - complications; Ischemia - complications; Leg - surgery; Leg Ulcer - etiology; Prostaglandins E - administration and dosage; Raynaud Disease - drug therapy